Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
Canada
Canadian Center for Vaccinology, Halifax, Nova Scotia Last updated December 2025